Background: The aim of the present metaanalysis was to investigate the correlation of serum homocysteine (Hcy) concentration and ulcerative colitis (UC) through pooling all the relevant publications.
Introduction
Homocysteine (Hcy), a sulfur-containing amino acid, is a product of methionine. Generally, homocysteine maintains a low level in serum in the human body under normal physiological conditions. Abnormally high levels of homocysteine in the serum, above 15 μmol/L, is a medical condition called hyperhomocysteinemia [1] . Hyperhomocysteinemia was considered to be a significant risk factor for the development of a wide range of diseases, including thrombosis [2, 3] , neuropsychiatric illness [4, 5] , and fractures [6, 7] . Hyperhomocysteinemia is also found to be associated with microalbuminuria, which is a strong indicator of the risk of developing renal dysfunction [8, 9] . Recently, several studies have reported the elevated serum Hcy in UC patients compared to healthy controls [10, 11] . A meta-analysis has also evaluated the genetic variants of homocysteine/folate metabolism pathway and risk of inflammatory bowel disease [12] . However, meta-analysis relevant to serum Hcy concentration and ulcerative colitis was not discussed in the previous literature. language was English or Chinese, (iii) UC was confirmed in the case group, and (iv) serum Hcy levels in UC patients and healthy controls can be extracted from the original studies. The publication exclusion criteria were (i) other study types such as case report or review, (ii) inflammatory bowel disease other than UC, and (iii) duplicated published data or studies.
Publication review and data extraction from each of the included study
The full text of the studies included in the meta-analysis were reviewed by two reviewers (Yifang Zhong & Feng Yan) independently. The general information and important data were extracted from each of the original publication. The information included (i) the first and corresponding authors of the included studies, (ii) the sample size, (iii) the country of study performed, (iv) the age of the UC group and healthy controls, (v) serum Hcy concentration examination methods, (vi) the quality of each included study (NOS score), and (vii) the serum level of Hcy of each original study.
Quality evaluation of each study
The general quality of the included eighteen studies was evaluated by Newcastle-Ottawa scale (NOS) [13] . The NOS ranges from 0 to 9 stars and the more stars the higher quality of the included case or cohort study.
Statistical analysis
All the data was analyzed by Stata10.0 SE software. The correlation between serum Hcy level and ulcerative colitis was expressed by stand mean difference (SMD). Before pooling the data, we fist evaluated the statistical heterogeneity across the included studies by I 2 test (I 2 >50%, random effect model; I 2 <=50%, fixed effect model), and then pooled the SMD by a fixed or random effect model.. The publication bias was evaluated through a Begg's funnel plot and Egger's test. Two tails p<0.05 was considered statistical significant.
Results

Main features of the included publications
After systematic searching the related electronic databases, eighteen publications relevant to serum Hcy and UC were finally included in the present meta-analysis. The publication electronic searching procedure is shown in Figure 1 . The general features of the included eighteen publications are demonstrated in Table 1 . Sample sizes ranged from 51 to 1063 subjects. The serum Hcy levels ranged from 10.10 to 20.67 μmol/L for UC groups and 6.80 to 13.21 μmol/L for control groups. The NOS score, which was used for evaluation the quality of the case-control studies, ranged from 4 to 6.
Serum Hcy concentration in UC and healthy controls
The serum Hcy levels were 14.01±2.76 and 10.31±1.59 μmol/L for UC group and healthy controls respectively. The serum Hcy concentration of UC group was significantly higher than that of controls with statistical difference (p<0.05), Figure 2 . 
Sensitivity analysis
Sensitivity analysis was performed by omitting each of the included publications. The pooled SMD changed from 0.93 (95% CI: 0.86-1.00) to 1.17 (95% CI: 1.09-1.25) by omitting each of the included studies, Table 2 . This indicates that the pooled SMD were not sensitive to any one of the included studies, Figure 4 . Ethical approval: The conducted research is not related to either human or animals use.
Publication bias analysis
The publications bias was evaluated by a funnel plot and Egger's line regression test. The funnel plot was asymmetrical at the bottom which demonstrated obvious publication bias ( Figure 5) . However, the Egger's line regression test indicated no publications bias (t=1.45, p=0.17).
Discussion
Ulcerative colitis is a chronic nonspecific inflammatory disease of the colon and rectum whose etiology is still unclear [30, 31] . The lesion are usually confined to the mucosa and submucosa of the large intestine. Most lesions are located in the sigmoid colon and rectum, but can also extend to the descending colon or even the whole colon [32, 33] . The course of the disease is long and often recurs. This disease occurs at any age, but the most common is 20-30 years old [34, 35] . The etiology of ulcerative colitis is still unknown. However, most studies believe that psychological factors play an important role in the occurrence and development of ulcerative colitis [36, 37] . Previously publications demonstrated that depression or anxiety was significantly improved after colectomy [38, 39] . Other studies showed that ulcerative colitis is an autoimmune disease [40, 41] .
Homocysteine is a non-proteinogenic α-amino acid. It is a homologue of the amino acid cysteine, differing by an additional methylene bridge (-CH2-). It is biosynthesized from methionine by the removal of its terminal C ε methyl group. Several studies have discussed the correlation between the serum homocysteine concentration and ulcerative colitis risk, and most of the publication found that the serum homocysteine was elevated in UC patients compared to healthy controls [10, 11] . However, other studies showed there was no statistical difference of serum Hcy concentration between UC groups and healthy controls [22] . Therefore, we performed this meta-analysis by pooling all the published data relevant to serum homocysteine concentration and ulcerative colitis in order to further evaluate their correlations and potential diagnostic performance as serological biomarker.
In the present meta-analysis, we included eighteen case-control studies published from 2005 to 2018. The pooled data indicated that the serum Hcy levels in UC groups were significantly higher than that of healthy controls (14.01±2.76 vs 10.31±1.59 μmol/L, p<0.05). This indicates that Hcy may play an important role in UC development and may be used as serological biomarker for UC diagnosis.
However, there were several limitations of the present meta-analysis: (i) significant statistical heterogeneity across the included studies, (ii) only studies published in English or Chinese were screened and included , and (ii) the general quality of the original publications was low.
In conclusion, increased serum Hcy levels were associated with the increased risk of UC. However, all the studies included were case-control studies, which can not reveal the causal relationship between Hcy level and UC. Therefore, more prospective cohort or basic studies relevant to Hcy and UC are needed to further evaluate the their correlation or provide more precise evidence. 
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